FDA 483 Citations for Returned Dietary Supplements Under 21 CFR 111.503
"You did not establish written procedures for [when a returned dietary supplement is received] [when a returned dietary supplement must be destroyed, or otherwise suitably disposed] [when a returned dietary supplement may be salvaged] [for conducting an investigation of your manufacturing processes and other batches for a returned dietary supplement] [quality control personnel to approve a returned dietary supplement for reprocessing]." FDA investigators cited 21 CFR 111.503 with that wording 54 times on system-generated Form FDA 483s in fiscal year 2025.
Returns are easy to overlook. A pallet comes back from a retailer, sits in the warehouse and is quietly put back into stock. Part 111 treats returns as a quality event: the product may have been stored badly, tampered with, or returned because something is wrong with it, and that problem may affect other batches.
What the citation means
Examples written after "Specifically" usually describe:
No written procedure for returns at all
Returned product placed back in saleable inventory with no review
Returned product not identified or quarantined
No quality control decision on whether to destroy, salvage or reprocess
Returns caused by quality complaints with no investigation of other batches
No records of returns and their disposition
What Part 111 requires
Procedures (111.503). You must establish and follow written procedures to fulfill the requirements of Subpart N, which covers returned dietary supplements.
Identification and quarantine (111.510). When a returned dietary supplement is received, you must identify and quarantine it until quality control personnel conduct a material review and make a disposition decision.
Disposition (111.515 and 111.520). A returned dietary supplement must be destroyed or otherwise suitably disposed of, unless quality control personnel approve it for salvage, for redistribution or for reprocessing.
Testing before salvage or reprocessing (111.525). Any returned dietary supplement that is reprocessed must meet all product specifications, and quality control personnel must approve or reject the release for distribution.
Investigation (111.530). When the reason for a return implicates associated batches, you must conduct an investigation of your manufacturing processes and each of those other batches to determine compliance with specifications.
Records (111.535). You must make and keep records of returned dietary supplements, including the material review and disposition decision and the results of any testing.
How to respond to the 483
Part 111 does not set a deadline for responding, but most firms respond in writing within 15 business days of the close of the inspection, so FDA has the response before it decides on further action.
Find returns already in the system
Identify returned product received in a defined period. Quarantine anything still in inventory. For returns put back into stock, trace where they went and assess the risk.
Write the returns procedure
Receipt, logging and identification of returns
Quarantine in a designated area or system status
Reason for return captured and screened for complaints
Quality control material review and disposition: destroy, salvage, redistribute or reprocess
Testing required before salvage or reprocessing
Investigation of other batches when the reason implicates them
Records
Connect returns to complaints
Many returns are complaints in disguise. Screen every return reason and log complaints under 111.553. Serious adverse events must be reported under FD&C Act section 761.
Train and verify
Train warehouse, customer service and quality control staff, and audit the returns log.
What a compliant returns procedure contains
Scope: retailer, distributor and consumer returns
Receipt, identification and quarantine
Reason capture and complaint screening
Quality control material review and disposition
Testing before salvage or reprocessing
Investigation of associated batches
Destruction records
Returns log and records
Common mistakes in returns responses
Restocking unopened returns without quality control review
Treating returns as a commercial matter only
Missing complaints hidden in return reasons
Investigating the returned batch but not others made the same way
Destroying product without records
Example: how one response section might read
This illustrates structure only; your response must describe your own facts.
Observation 8: You did not establish written procedures for returned dietary supplements. Specifically, 36 cases returned by a distributor were placed back into finished goods inventory without quality control review.
Response:
Correction: The 36 cases were located and quarantined. Quality control reviewed storage records and tested reserve and returned samples, and approved 30 cases for redistribution and rejected six with damaged seals on a stated date.
Corrective action: A returned products procedure was issued, covering quarantine, quality control disposition, testing before salvage and investigation of associated batches.
Complaint link: Return reasons are now screened by quality control, and two returns from the past year were logged as complaints.
Training: Warehouse, customer service and quality control staff were trained.
Frequently asked questions
Can unopened returns go back into stock?
Only after quality control conducts a material review and approves it. Storage conditions outside your control may have affected the product.
When must other batches be investigated?
When the reason for the return implicates associated batches, for example a potency failure or contamination that could stem from a component or process used in other batches.
Do returns need to be logged as complaints?
When the reason for return is a complaint, it must be handled under the complaint procedures in Subpart O.
How A.P. Lyon documents help
A.P. Lyon's Dietary Supplement cGMP Quality System (21 CFR 111) includes a returned dietary supplement procedure with quarantine, quality control disposition, salvage testing and batch investigation, plus a returns log. The Supplement Brand Owner Compliance Pack covers returns for brand owners who distribute product made by others.
Documents are editable Word and Excel files and must be adapted to your operations. Your staff must be trained and the procedures followed.
Next steps
Find and quarantine returns already in inventory
Write and train on a returns procedure
Screen return reasons for complaints
Respond in writing within 15 business days with dates for each action
Related guides: Product Complaint Citations and Holding and Distribution Citations.
To compare the complete system with the brand owner pack, see all dietary supplement documents.
Not sure where your quality system stands? Take the free QMS gap check: about 20 questions, an instant report of your gaps by clause, and the procedures that close each one.



Comments